Skip to Main Content

Author Details

Peter A Fasching
Otto-Friedrich-University Bamberg
2002
753
93
PMIDPaper TitleJournal TitlePublished Year
37532863Effects of prenatal alcohol exposition on cognitive outcomes in childhood and youth: a longitudinal analysis based on meconium ethyl glucuronide.Eur Arch Psychiatry Clin Neurosci2024
37635683Multicenter evaluation of blood-based biomarkers for the detection of endometriosis and adenomyosis: A prospective non-interventional study.Int J Gynaecol Obstet2024
37602372Association between event-free survival and overall survival in early-stage triple-negative breast cancer.Future Oncol2024
36222516Deactivating attachment strategies associate with early processing of facial emotion and familiarity in middle childhood: an ERP study.Attach Hum Dev2023
37916184Update Breast Cancer 2023 Part 2 - Advanced-Stage Breast Cancer.Geburtshilfe Frauenheilkd2023
37916183Update Breast Cancer 2023 Part 1 - Early Stage Breast Cancer.Geburtshilfe Frauenheilkd2023
37862832Favorable impact of therapy management by an interactive eHealth system on severe adverse events in patients with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy.Cancer Treat Rev2023
37803017Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study.NPJ Breast Cancer2023
37523663Quality of Life and Treatment-Related Side Effects in Patients With HR+/HER2- Advanced Breast Cancer: Findings From a Multicountry Survey.Oncologist2023
37958196Improving the Quality of Care for Cancer Patients through Oncological Second Opinions in a Comprehensive Cancer Center: Feasibility of Patient-Initiated Second Opinions through a Health-Insurance Service Point.Diagnostics (Basel)2023
37706057Treatment of Early Breast Cancer: The 18th St. Gallen International Breast Cancer Consensus Conference against the Background of Current German Treatment Recommendations.Geburtshilfe Frauenheilkd2023
37706055Update Breast Cancer 2023 Part 3 - Expert Opinions of Early Stage Breast Cancer Therapies.Geburtshilfe Frauenheilkd2023
37623237Ex Vivo Chromosomal Radiosensitivity Testing in Patients with Pathological Germline Variants in Breast Cancer High-Susceptibility Genes <i>BReast CAncer 1</i> and <i>BReast CAncer 2</i>.Curr Issues Mol Biol2023
37900552Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2023.Breast Care (Basel)2023
37900553AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2023.Breast Care (Basel)2023
37657462Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study.Lancet Oncol2023
37653397Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2- advanced breast cancer receiving first-line ribociclib plus fulvestrant.Breast Cancer Res2023
37614683Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer - Controversies and Standards in Healthcare.Geburtshilfe Frauenheilkd2023
37612624Neoadjuvant immunotherapy and chemotherapy regimens for the treatment of high-risk, early-stage triple-negative breast cancer: a systematic review and network meta-analysis.BMC Cancer2023
37834786Effects of an App-Based Mindfulness Intervention during Pregnancy on the Infant's Prenatal Androgen Exposure: A Randomized Controlled Pilot Trial.J Clin Med2023
37503126Understanding the genetic complexity of puberty timing across the allele frequency spectrum.medRxiv2023
37821584Prevalence and course of pregnancy symptoms using self-reported pregnancy app symptom tracker data.NPJ Digit Med2023
37499979Association of two genomic variants with HPV type-specific risk of cervical cancer.Tumour Virus Res2023
37770952Predicting mammographic density with linear ultrasound transducers.Eur J Med Res2023
37570360The Father's Part: Influences of Paternal Psychopathology and Parenting Behavior on Child and Adolescent Well-Being.Healthcare (Basel)2023
37536278Evaluating the Effectiveness of Mobile Health in Breast Cancer Care: A Systematic Review.Oncologist2023
37725572RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial.Clin Cancer Res2023
35680688Genetic variants in the genes of the sex steroid hormone metabolism and depressive symptoms during and after pregnancy.Arch Gynecol Obstet2023
370846922D:4D biomarker reliability and validity in a within-subject pregnancy-childhood-adolescence cohort.Early Hum Dev2023
36948887p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2023
37451831Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.J Med Genet2023
37014668Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial.Clin Cancer Res2023
36981624Association of Maternal Smoking during Pregnancy with Neurophysiological and ADHD-Related Outcomes in School-Aged Children.Int J Environ Res Public Health2023
37445258Feasibility and Acceptance of Self-Guided Mobile Ultrasound among Pregnant Women in Routine Prenatal Care.J Clin Med2023
37179020Patient-reported outcomes and hospitalization data in patients with HER2-positive metastatic breast cancer receiving trastuzumab deruxtecan or trastuzumab emtansine in the phase III DESTINY-Breast03 study.Ann Oncol2023
36980649CDK4/6 Inhibitors-Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer.Cancers (Basel)2023
36980588The Chorioallantoic Membrane Xenograft Assay as a Reliable Model for Investigating the Biology of Breast Cancer.Cancers (Basel)2023
37444426Spectrum and Frequency of Germline <i>FANCM</i> Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases.Cancers (Basel)2023
37238414The Benefit of a Retrospective Pregnancy Anamnesis in Child and Adolescent Psychiatry: The Reliability of Maternal Self-Report during Childhood Development.Children (Basel)2023
37275963Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclibâ¿¿+â¿¿endocrine therapy <i>versus</i> endocrine therapy alone in patients with HR+/HER2- early breast cancer.Ther Adv Med Oncol2023
37336651Association Between Obesity and Circulating Tumor Cells in Early Breast Cancer Patients.Clin Breast Cancer2023
37201751Significantly longer time to deterioration of quality of life due to CANKADO PRO-React eHealth support in HR+ HER2- metastatic breast cancer patients receiving palbociclib and endocrine therapy: primary outcome analysis of the multicenter randomized AGO-B WSG PreCycle trial.Ann Oncol2023
37432976Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial.Clin Cancer Res2023
37029138Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy.NPJ Breast Cancer2023
36449103Sex-specific association between prenatal androgenization (second-to-fourth digit length ratio) and frontal brain volumes in adolescents.Eur Arch Psychiatry Clin Neurosci2023
36409394Return of individual genomic research results within the PRAEGNANT multicenter registry study.Breast Cancer Res Treat2023
36401943Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery.Gynecol Oncol2023
36611077Evaluation of automated techniques for extraction of circulating cell-free DNA for implementation in standardized high-throughput workflows.Sci Rep2023
36689693Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival.J Clin Oncol2023
36688720Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.J Natl Cancer Inst2023
  • 1 - 50 of 753

Recommended Authors

Florentine S Hilbers
Netherlands Cancer Institute
Career Start Year 2012
Number of shared co-authors 29
Carmen Criscitiello
University of Milano
Career Start Year 2008
Number of shared co-authors 10
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 12
Sharon F McGee
The Ottawa Hospital Cancer Centre
Career Start Year 2006
Number of shared co-authors 1
Catherine M Kelly
Mater Misericordiae University Hospital
Career Start Year 2006
Number of shared co-authors 15
Christina Yau
University of California San Francisco
Career Start Year 2005
Number of shared co-authors 24
Katherine D Crew
Columbia University Irving Medical Center
Career Start Year 2004
Number of shared co-authors 5
Larissa A Korde
Clinical Investigations Branch, National Cancer Institute
Career Start Year 2004
Number of shared co-authors 33
David W Cescon
Princess Margaret Cancer Centre
Career Start Year 2003
Number of shared co-authors 14
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 19
Nicola Fusco
IEO European Institute of Oncology IRCCS
Career Start Year 2002
Number of shared co-authors 3
Richard B Schwab
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 4
Massimo Cristofanilli
Weill Cornell School of Medicine
Career Start Year 1998
Number of shared co-authors 13
Carolien P Schr??der
University of Groningen, University Medical Center Groningen
Career Start Year 1995
Number of shared co-authors 14
Naoto T Ueno
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Career Start Year 1995
Number of shared co-authors 11
Steven J Isakoff
Massachusetts General Hospital
Career Start Year 1995
Number of shared co-authors 10
Annette Hasenburg
University Medical Center, Johannes Gutenberg University Mainz
Career Start Year 1994
Number of shared co-authors 9
Maria Aparecida Azevedo Koike Folgueira
Center for Translational Oncology, Cancer Institute of the State of Sao Paulo - ICESP
Career Start Year 1993
Number of shared co-authors 2
Abenaa M Brewster
The University of Texas MD Anderson Cancer Center
Career Start Year 1993
Number of shared co-authors 11
Daniel Rea
Institute of Cancer and Genomic Sciences, The University of Birmingham
Career Start Year 1993
Number of shared co-authors 11
John M S Bartlett
University of Edinburgh
Career Start Year 1992
Number of shared co-authors 41
Ramona F Swaby
Merck & Co., Inc.
Career Start Year 1991
Number of shared co-authors 9
Peggy L Porter
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 24
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 21
Paul J van Diest
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 23
Alberto Zambelli
IRCCS Humanitas Research Hospital
Career Start Year 1987
Number of shared co-authors 13
Christos Markopoulos
National and Kapodistrian University of Athens
Career Start Year 1987
Number of shared co-authors 6
Clifford A Hudis
Memorial Sloan Kettering Cancer Center, USA American Society of Clinical Oncology
Career Start Year 1987
Number of shared co-authors 36
Stefan Aebi
University of Bern
Career Start Year 1985
Number of shared co-authors 15
Kathleen I Pritchard
UCL Great Ormond Street Institute of Child Health, University College London
Career Start Year 1976
Number of shared co-authors 31

Collaborators

Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 186
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 177
Douglas F Easton
University of Cambridge
Co-authored papers 163
Graham G Giles
Co-authored papers 155
Diether Lambrechts
Co-authored papers 153
Fergus J Couch
Mayo Clinic
Co-authored papers 144
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 143
Per Hall
Co-authored papers 140
Montserrat Garcia-Closas
National Cancer Institute
Co-authored papers 130
Alison M Dunning
Co-authored papers 127
Jan Lubinski
Pomeranian Medical University
Co-authored papers 126
Hoda Anton-Culver
University of California irvine
Co-authored papers 125
Roger L Milne
Co-authored papers 114
Irene L Andrulis
University of Toronto
Co-authored papers 110
Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 106
Christopher A Haiman
University of Southern California
Co-authored papers 92
Vessela N Kristensen
Faculty of Clinical Medicine, University of Oslo
Co-authored papers 92
Jonine D Figueroa
The Usher Institute, The University of Edinburgh
Co-authored papers 90
Anna H Wu
University of Southern California
Co-authored papers 90
Jolanta Lissowska
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Co-authored papers 85
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 84
Janet E Olson
Mayo Clinic
Co-authored papers 81
Wei Zheng
Co-authored papers 81
Paolo Radice
Ospedale Circolo e Fondazione Macchi
Co-authored papers 77
Loic Le Marchand
Co-authored papers 74
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 73
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 65
Julia A Knight
Co-authored papers 65
Jonathan Tyrer
Co-authored papers 65
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 65
Release 1.2